Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
PPCB
PPCB
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
PPCB News
Propanc Publishes Key Findings on PRP's Potential Efficacy Against Pancreatic Cancer
Dec 22 2025
Globenewswire
Propanc Biopharma, Inc. Obtains Up to $100 Million in Private Placement to Enhance Digital Asset Acquisition and Speed Up R&D Initiatives
Nov 10 2025
Newsfilter
Correction: Propanc Biopharma Reveals Strategic Financing Deal Worth Up to $100 Million with Hexstone Capital
Oct 15 2025
Newsfilter
Propanc Shares Key Highlights from Fiscal Year End and Details on Therapeutic Development & $100M+ Digital Asset Treasury Plan
Oct 07 2025
Newsfilter
Propanc Biopharma reveals intention to purchase $100 million in Ethereum
Sep 02 2025
SeekingAlpha
Propanc Biopharma Issues Update for Shareholders
Aug 25 2025
Newsfilter
Rocket Pharmaceuticals Shares Surge Over 15%; Check Out 20 Stocks Making Moves in Premarket Trading
Aug 20 2025
Benzinga
What’s Happening with Propanc Shares This Monday?
Aug 18 2025
Benzinga
Monday's Major Stock Market Highlights: Morning News Summary
Aug 18 2025
TipRanks
Crude Oil Prices Rise as US Homebuilder Confidence Falls in August
Aug 18 2025
Benzinga
US Stocks Show Varied Performance; Riskified Shares Decline Following Q2 Earnings Report
Aug 18 2025
Benzinga
What’s Behind the 150% Surge in Propanc Biopharma Stock (PPCB) Today?
Aug 18 2025
TipRanks
Dayforce Shares Surge Approximately 21%; Check Out 20 Stocks Making Moves in Premarket Trading
Aug 18 2025
Benzinga
Premarket Stock Movements: PPCB, BTAI, TNXP, DAY, TPIC, and Other Notable Gainers and Losers
Aug 18 2025
NASDAQ.COM
Show More News
